- Home
- ABEV vs BDX Comparison
ABEV vs BDX Comparison
Compare ABEV & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ABEV | BDX |
|---|---|---|
| Founded | 1885 | 1897 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Medical/Dental Instruments |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.8B | 40.3B |
| IPO Year | 2012 | 1997 |
Fundamental Metrics
Financial Performance| Metric | ABEV | BDX |
|---|---|---|
| Price | $3.14 | $147.47 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 4 | 13 |
| Target Price | $2.94 | ★ $186.00 |
| AVG Volume (30 Days) | ★ 27.9M | 2.4M |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | ★ 4.93% | 2.89% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.25 |
| Revenue | N/A | ★ $21,840,000,000.00 |
| Revenue This Year | $7.96 | N/A |
| Revenue Next Year | $5.35 | $3.02 |
| P/E Ratio | ★ $16.99 | $575.68 |
| Revenue Growth | N/A | ★ 8.24 |
| 52 Week Low | $2.10 | $140.11 |
| 52 Week High | $3.45 | $213.08 |
Technical Indicators
Market Signals| Indicator | ABEV | BDX |
|---|---|---|
| Relative Strength Index (RSI) | 47.59 | 51.27 |
| Support Level | $3.04 | $142.48 |
| Resistance Level | $3.23 | $153.09 |
| Average True Range (ATR) | 0.06 | 3.42 |
| MACD | -0.01 | -0.10 |
| Stochastic Oscillator | 31.46 | 54.91 |
Price Performance
Historical ComparisonAbout ABEV Ambev S.A.
Ambev is the largest brewer in Latin America and the Caribbean and is Anheuser-Busch InBev's subsidiary in the region. It produces, distributes, and sells beer and PepsiCo products in Brazil and other Latin American countries and owns Argentina's largest brewer, Quinsa. Ambev was formed in 1999 through the merger of Brazil's two largest beverage companies, Brahma and Antarctica. In 2004, Ambev combined with Canadian brewer Labatt, giving AB InBev a controlling interest of 62%.
About BDX Becton Dickinson and Company
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.